The lowering of the price target by Goldman Sachs suggests a slightly less optimistic view on Gentex's future performance, which could lead to a short-term negative impact on the stock price. The Neutral rating indicates no strong buy or sell recommendation, but the reduced price target may influence investor sentiment.